Se-cure Pharmaceuticals

Botanical Drug Development

Health Tech & Life Sciences
Active
Mature Lod, Israel Founded 1997
Last updated 2026-06-18
Total raised
$14.0M
Last: 2010-12
Stage
Mature
Founded
1997
Headcount
19
HQ
Lod, Israel
Sector
Health Tech & Life Sciences

About

Se-cure Pharmaceuticals is a clinical-stage, technology-driven pharmaceutical company focused on developing safe and effective therapeutic solutions derived from botanical sources. By implementing proprietary botanical drug development and scaling technologies, Se-cure seeks to introduce novel biochemical agents characterized by selective mechanisms of action in the target tissues. The company's methodology for developing drugs from botanical sources is in accordance with US FDA botanical drug development guidelines. Se-cure establishes large-scale human and post-marketing data by using over-the-counter pilot sales of its botanical therapeutics, helping the company produce both efficacy and safety data and substantially increasing the agent's probability of success in phase-3 studies. Se-cure's current pipeline includes six botanical drug candidates whose targets include women's health and osteoporosis management, men's health and benign hyperplasia management, burn injury management, and dental bone rejuvenation.

Funding history · 1 round · $14.0M total

Q&A

What is Se-cure Pharmaceuticals' primary focus?
Se-cure Pharmaceuticals is a clinical-stage pharmaceutical company focused on developing safe and effective therapeutic solutions derived from botanical sources.
When was Se-cure Pharmaceuticals founded?
Se-cure Pharmaceuticals was founded in March 1997.
How many employees does Se-cure Pharmaceuticals have?
Se-cure Pharmaceuticals has 11-50 employees.
What is the total amount of funding Se-cure Pharmaceuticals has raised?
Se-cure Pharmaceuticals has raised a total of $14,000,000.
When was Se-cure Pharmaceuticals' last funding round?
Se-cure Pharmaceuticals' last funding round occurred in December 2010.
Which investors participated in Se-cure Pharmaceuticals' December 2010 funding round?
Investors in Se-cure Pharmaceuticals' December 2010 funding round included Heartwood Holdings and Pontifax.
What is Se-cure Pharmaceuticals' current product pipeline focused on?
Se-cure Pharmaceuticals' current pipeline includes six botanical drug candidates targeting women's health, osteoporosis management, men's health, benign hyperplasia management, burn injury management, and dental bone rejuvenation.
In which country is Se-cure Pharmaceuticals headquartered?
Se-cure Pharmaceuticals is headquartered in Lod, Israel.

Sectors & technology

Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesPharma & Medical BiotechnologyDrugs Discovery & Development
Technologies
BiologicalsHerbals
Target customers
Commerce & RetailConsumer GoodsBeauty & CosmeticsHealthcare & Life SciencesLife SciencesCosmeticsPharmaceuticals
Business model
B2B2C

Highlights

1 Patents

Tags

biochemical-compoundsburnswomen-healthbiotechnologydentaltherapeuticscosmeticspatientswomenpharma-companiesfemtech
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)